Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

AME

Analyzing AMETEK – A Deep Dive into the Stock

Shares of AMETEK have moved 2.6% today, and are now trading at a price of $203.44. In contrast, the S&P 500 index saw a 1.0% change. Today's trading volume is 1,524,366 compared to the stock's average volume of 1,219,189.

AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. Based in Berwyn, United States the company has 21,500 full time employees and a market cap of $46,985,273,344. AMETEK currently offers its equity investors a dividend that yields 0.6% per year.

The company is now trading -5.53% away from its average analyst target price of $215.35 per share. The 17 analysts following the stock have set target prices ranging from $180.0 to $246.0, and on average give AMETEK a rating of buy.

Over the last 52 weeks, AME stock has risen 11.1%, which amounts to a -7.9% difference compared to the S&P 500. The stock's 52 week high is $203.49 whereas its 52 week low is $145.02 per share. Based on AMETEK's average net margin growth of 2.6% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 6,941,180 1,376,124 20 0.0
2023 6,596,950 1,313,188 20 5.26
2022 6,150,530 1,159,542 19 5.56
2021 5,546,514 990,053 18 -5.26
2020 4,540,029 872,439 19 11.76
2019 5,158,557 861,297 17
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS